A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis
Latest Information Update: 28 Nov 2018
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 24 Oct 2018 Results presented in the Amgen media release.
- 27 Oct 2017 Status changed from active, no longer recruiting to completed.